Phenox GmbH
phenox GmbH is an innovative medical technology company based in Germany that, since its founding in 2005, has specialized in the development of pioneering, clinically proven technologies to treat neurovascular diseases. The company offers a broad portfolio of highly developed, minimally invasive products, including mechanical thrombectomy systems such as the pREset, the p64 Flow Modulation Device for the treatment of complex intracranial aneurysms and dissections, and the pCONus Implant, which was specifically developed for the treatment of complex, wide-necked intracranial bifurcation aneurysms. These products are used internationally by endovascular specialists to effectively treat both ischemic and hemorrhagic strokes[1][5].
The main mission of phenox is to revolutionize the treatment of neurovascular diseases through innovative medical technology, thereby sustainably improving the quality of life of patients worldwide. The company places great emphasis on evidence-based research and close collaboration with clinical partners to continuously optimize and clinically validate its products. The values of phenox are based on quality, innovation, patient safety and a responsible use of resources[1].
Sustainability is also an important priority at phenox, particularly through the development of durable and efficient systems that contribute to better patient treatment in clinical practice while reducing resource consumption. Although specific environmental goals of phenox are less prominent, the company's practice in medical technology as a whole shows a tendency towards sustainable production and development approaches. In addition, the use of minimally invasive procedures helps to reduce hospital stays and complications, which indirectly has positive ecological and social effects.
In 2023, a merger with Wallaby Medical took place to create a world-leading company for neurovascular products and thus accelerate global growth. This illustrates the international orientation and the aspiration of phenox to make its innovative solutions accessible to an ever-wider patient base[3].
In summary, phenox GmbH is a technologically highly modern company that makes a significant contribution to improving stroke therapy through its specialized medical technology products, combines scientific excellence with patient-centered innovation, and consistently drives forward its global expansion.
